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conditionally LC deficient. Expression 
of the Birbeck granule–associated 
C-type lectin Langerin is characteris-
tic of LCs. Kaplan and colleagues used 
the upstream regulatory region of the 
human Langerin gene to express the 
A subunit of diphtheria exotoxin (DTA) 
in LCs in transgenic mice (Kaplan et al., 
2005). DTA catalyzes the ADP ribosyla-
tion of elongation factor-2, inactivating 
it, inhibiting translation, and thereby 
causing cell death. In Langerin–DTA 
mice, LCs are deleted as soon as the 
Langerin gene is expressed. Two other 
groups—headed by Clausen (Bennett et 
al., 2005) and Malissen (Kissenpfennig 
et al., 2005)—independently gener-
ated mice in which a cDNA encod-
ing the diphtheria toxin receptor 
(DTR) was inserted into the Langerin 
locus by homologous recombination 
(Langerin–DTR mice). LCs are present 
in Langerin–DTR mice until the admin-
istration of diphtheria toxin (DT). A 
single intraperitoneal treatment results 
in virtually complete depletion of LCs 
within 2 days. Because mouse cells do 
not normally express high-affinity DTR, 
normal mice and cells in Langerin–DTR 
mice that do not express DTR are insen-
sitive to DT’s deleterious effects.
Thus, Langerin–DTA mice differ 
from DT-treated Langerin–DTR mice 
in that the former never have LCs, 
whereas the latter have a normal con-
tingent of LCs until DT is adminis-
tered. Recently it was recognized that 
these mice differ in another important 
way. Several groups have reported that 
(in mice) Langerin is expressed by a 
subpopulation of lymph node DCs (so-
called CD8α+ DCs), as well as some, 
but not all, DCs that are present in the 
dermis (Bursch et al., 2007; Ginhoux 
et al., 2007; Poulin et al., 2007). It is 
believed that the Langerin+ CD8α+ 
DCs and at least some Langerin+ der-
mal DCs are not related to epidermal 
LCs. Interestingly, Langerin–DTA mice 
appear to have normal numbers of 
Langerin+ DCs in lymph nodes and in 
the dermis (Bursch et al., 2007). Based 
on these results, it might be antici-
pated that treatment of Langerin–DTR 
mice with DT would lead to a similar 
selective loss in LCs. This is not the 
case, however. The injection of DT into 
Langerin–DTR mice leads to rapid and 
Another challenge relates to the fact 
that individual tissues are often popu-
lated by several DC subpopulations. For 
example, although it is true that LCs are 
the only DCs present in unperturbed 
epidermis, murine dermis contains at 
least three identifiable DC subpopula-
tions (Bursch et al., 2007; Ginhoux et 
al., 2007; Poulin et al., 2007). The func-
tional capabilities of seemingly distinct 
DC subpopulations have not yet been 
fully characterized, but it is possible 
that in some instances they may be able 
to compensate for one another whereas 
in other instances their functions may 
be very different. An additional major 
(and related) challenge results from 
complexities of the immune responses 
that are studied to gain insights into LC/
DC function. Although it is relatively 
straightforward to conduct contact 
hypersensitivity or skin graft rejection 
experiments, the ensuing immune 
responses develop and are expressed 
over days to weeks, and they involve 
many kinds of cells that interact in dis-
tinct anatomic locations.
The availability of increasingly 
sophisticated in vivo models that 
result from manipulation of the mouse 
genome has allowed several of these 
challenges to be overcome. Some of 
the most interesting new insights into 
LC physiology have come from studies 
of mice that are constitutively LC 
deficient and mice that can be made 
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Langerhans cells (LCs) represent the epi-
dermal contingent of the dendritic cell 
(DC) lineage. DCs are potent antigen-
presenting (accessory) cells that are crit-
ical for the initiation and propagation 
of T-cell-dependent immune responses. 
Although LCs may be the most studied 
tissue DCs, and although it has long 
been thought that they are “prototypic” 
(and, by inference, “representative”) of 
immature myeloid DCs, the results of 
recent studies indicate that LCs have 
several distinct characteristics. They are 
long-lived relative to other DCs, are rel-
atively radioresistant, and, among DCs, 
are uniquely dependent on transform-
ing growth factor-β1 for development, 
survival, and localization. One might 
predict (or even expect) that LCs must 
have distinct functional characteristics, 
but definitive data that support this 
concept have been unavailable until 
recently.
One challenge associated with try-
ing to determine how DCs, including 
LCs, participate in immune responses 
in mice or humans is that their phe-
notypes and functional activities are 
influenced by their surrounding envi-
ronments. As a result, in vitro studies of 
functional properties of LCs/DCs may 
or may not be reflective of their func-
tional activities in situ. Thus, individual 
studies involving varying experimen-
tal conditions may lead to conflicting 
results rather than a unifying picture. 
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virtually complete loss of Langerin-
expressing cells from the epidermis, the 
dermis, and lymph nodes. The situa-
tion is additionally complicated by the 
observation that Langerin+ DCs repop-
ulate different anatomic sites with very 
different kinetics (Poulin et al., 2007). 
Normal numbers of Langerin+ DCs are 
reestablished in the dermis and lymph 
nodes of Langerin–DTR mice within a 
few days after DT treatment, whereas 
epidermal LC frequencies do not com-
pletely normalize for months.
Both Langerin–DTA and Langerin–
DTR mice are being used as tools with 
which to characterize the involve-
ment of LCs in skin-centered immune 
responses in vivo. Contact hypersen-
sitivity experiments have been care-
fully conducted with all three lines 
of LC-deficient mice (Langerin–DTA 
mice and the two independently gen-
erated Langerin–DTR mice). Two stud-
ies (one involving Langerin–DTA mice 
and one using the Langerin–DTR mice 
generated by Kissenpfennig et al., 
2005) failed to confirm a requirement 
for LCs in the initiation or elicitation 
phases of contact hypersensitivity 
reactions (Kaplan et al., 2005; Wang 
et al., 2008). The results of other stud-
ies that make use of the Langerin–DTR 
mice made by Clausen and cowork-
ers indicate that LCs are required for 
optimal hapten sensitization (Bennett 
et al., 2005, 2007). These discrepan-
cies appear to result from differences 
in the timing of DT administration in 
relation to hapten treatment in the two 
sets of experiments.  Results of two 
subsequent carefully performed time 
course studies (Bursch et al., 2007; 
Wang et al., 2008) have demonstrated 
that it is Langerin+ dermal DCs, rather 
than LCs, that are required for optimal 
priming to contact allergens. 
Interestingly, Kaplan and coworkers 
reported an approximately two-
fold enhancement of contact hyper-
sensitivity reactions in Langerin–DTA 
mice as compared with nontrans-
genic control animals, rather than a 
decrease (Kaplan et al., 2005). On 
the basis of these observations, the 
authors suggested that LCs may be 
negative regulators of certain immune 
responses. Enhancement of contact 
hypersensitivity reactions has not been 
observed in any experiments involv-
ing LC-deficient Langerin–DTR mice, 
however. As a possible explanation for 
this discrepancy, it has been suggested 
that the constitutive absence of LCs 
in Langerin–DTR mice has resulted in 
altered immunophysiology that is not 
replicated in Langerin–DTR mice that 
are rendered acutely LC deficient.
This issue of the Journal of Investigative 
Dermatology contains another inter-
esting paper that describes the results 
of experiments obtained in studies of 
LC-deficient mice. In this paper, Obhrai 
and colleagues (2008) have systemati-
cally assessed the role that LCs play in 
skin graft rejection using Langerin–DTA 
mice. The results are striking, unexpect-
ed, and provocative.
Full-thickness (epidermis plus 
dermis) trunk skin grafts from 
Langerin–DTA and littermate controls 
were grafted onto normal recipients. 
When the donors were FVB (H-2q) 
mice and the recipients were C57BL/6 
(H-2b) mice, all grafts were rejected 
with identical kinetics, independent 
of whether they were obtained from 
LC-deficient or LC-sufficient animals. 
In this experiment, donors and recipi-
ents were mismatched at all major 
histocompatibility complex (MHC) 
loci and multiple minor histocompat-
ibility loci as well. A similar result was 
obtained when grafts obtained from 
male, partially backcrossed C57BL/6 
Langerin–DTA mice were placed onto 
normal female C57BL/6 mice. In this 
experiment, donors and recipients 
were matched at all MHC loci but 
were disparate with respect to male-
associated antigens (including H-Y) 
and, because of incomplete back-
crossing, probably some minor loci 
as well. Interpretation of these sets 
of experiments indicates that LCs are 
not required for initiation of skin graft 
rejection. This conclusion is well sup-
ported by the data that have been pre-
sented, although it is a bit curious that 
the grafts that were male-antigen mis-
matched were rejected just as quickly 
as those that differed across the entire 
MHC. Perhaps this can be attributed 
to mismatches of multiple additional 
minor histocompatibility antigens.
The results of experiments that 
assessed the role of LCs in rejection 
of male FVB skin grafts by female FVB 
mice were surprising. The ability of 
female mice to reject skin grafts from 
male mice is strain dependent. B6 
females reject B6 male grafts, whereas 
FVB females accept FVB male grafts. 
Obhrai et al. (2008) reproduced these 
observations and went on to dem-
onstrate that this finding held only if 
FVB male skin grafts contained LCs. 
Skin grafts obtained from male FVB 
Langerin–DTA mice were almost always 
rejected, albeit less rapidly than seen in 
the studies with B6 mice. The authors 
attempted to identify a mechanism 
that could explain these results, but the 
mechanism remains undefined. It does 
not appear that differential engraftment 
can be attributed to differential T-cell 
priming, Th1 versus Th2 development, 
or regulatory T-cell expansion.
The data presented in the article 
by Obhrai et al. (2008) clearly indi-
cate that LCs are not required for skin 
graft rejection. Because the skin of 
Langerin–DTA mice is replete with der-
mal DCs, it seems likely that it is these 
cells rather than LCs that are critical 
for alloantigen-specific T-cell prim-
ing in these experiments. This is not 
very surprising. How might LCs inhibit 
male antigen-associated skin graft 
rejection in FVB mice? Although we 
have no mechanistic insight at present, 
the finding should not be ignored or 
passed over as an artifact associated 
with an understudied (from an immu-
nologist’s point of view) mouse strain. 
Historically, studies of inbred mouse 
strains that exhibit very different types 
of immune responses have been highly 
informative. Indeed, one could make 
the case that the importance of Th1 and 
Th2 T-cell subsets in vivo first became 
clear from studies of the differential 
susceptibility of C57BL/6 and BALB/c 
mice to develop progressive disease 
after infection with Leishmania major.
|LCs are not soloists but rather part of an immunologic orchestra.
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It is interesting to note that Girardi et 
al. (2002) previously implicated another 
epidermal leukocyte subset, dendritic 
epidermal T cells (DETCs), as negative 
regulators of skin inflammation and 
described a DETC-related strain differ-
ence between C57BL/6 and FVB mice. 
T-cell receptor δ-chain-deficient FVB 
mice develop dermatitis spontaneously 
and also exhibit exacerbated irritant 
dermatitis as compared with their B6 
counterparts. Furthermore, both the 
spontaneous and the irritant dermatitis 
in FVB δ-deficient mice could be atten-
uated by reconstitution with DETC pre-
cursors, proving that the DETCs are the 
relevant regulatory cells.
In discussing their JID study, Obhrai 
and coworkers cite a paper by Oh et 
al., in which a negative regulatory role 
for CD1d-restricted NKT cells in male-
associated antigen-dependent skin graft 
rejection is described (Oh et al., 2005). 
In these experiments, male skin grafts 
were rejected more quickly by female 
CD1d knockout mice than by wild-
type mice. NKT cells and DETCs share 
a number of phenotypic and functional 
characteristics (Nixon-Fulton et al., 
1988; Kaminski et al., 1993; Jamieson 
et al., 2002). Perhaps the results report-
ed in this issue of JID are clueing us in 
to the existence of a negative regulatory 
circuit that involves LCs as accessory 
cells and DETCs as regulatory cells, that 
is more active in some mouse strains 
than others, and that is relevant only 
when antigenic responses are relative-
ly weak (as in the case of single minor 
transplantation antigen mismatches 
or when antigens are associated with 
commensal organisms, for example).
Speculation that is not constrained 
by data is part of the fun of being an 
investigator, and unexpected and 
unexplained dramatic findings such 
as those reported in the paper from 
Kaplan’s group provoke it. It seems 
likely that we will have learned some-
thing fundamental about how some 
skin-centered responses are regu-
lated when we come to understand 
the mechanism behind LC-dependent 
engraftment of FVB male skin onto 
FVB females. We hope that the expla-
nation will be forthcoming soon.
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